Nick Harvey has served as Adicet Bio's Chief Financial Officer since the completion of the merger. He previously served as CFO from July 2018 and EVP and Treasurer from October 2018 of Centrexion Therapeutics until December 2019, then as Senior Advisor through January 2020.
From June 2017 through June 2018 he was an independent consultant to private and public life-science companies, and earlier served as CFO of Radius Health from December 2006 to May 2017. He received a Bachelor of Economics and a Bachelor of Laws with first-class honors from the Australian National University and an MBA from Harvard Business School.